共 50 条
- [21] ANTI-TUMOR ACTIVITY AND MECHANISMS OF ACTION OF PHYTOEXTRACTS ON ACUTE MYELOID LEUKEMIA CELLSHAEMATOLOGICA, 2019, 104 : 138 - 138Lamorte, D.Laurenzana, I.Trino, S.Faraone, I.Milella, L.Russo, D.De Luca, L.Caivano, A.Musto, P.
- [22] An orally bioavailable small molecule antagonist of TIM-3 signaling pathway shows potent anti-tumor activityCANCER RESEARCH, 2019, 79 (13)Sasikumar, Pottayil G.Naremaddepalli, Sudarshan S.Ramachandra, Raghuveer K.Gowda, NageshDevarapalli, SrinivaskumarAdurthi, SreenivasMani, JijuNair, RashmiDhudashiya, Amit A.Samiulla, Dodheri S.Gowda, Nagaraj M.Ramachandra, Murali
- [23] BAY 1143572, a first-in-class, highly selective, potent and orally available inhibitor of PTEFb/CDK9 currently in Phase I, shows convincing anti-tumor activity in preclinical models of acute myeloid leukemia (AML)CANCER RESEARCH, 2016, 76Scholz, ArneOellerich, ThomasHussain, AkhtarLindner, SarahLuecking, UlrichWalter, Annette O.Ellinghaus, PeterValencia, Rayvon Nussbaum, FranzMumberg, DominikBrands, MichaelInce, StuartServe, HubertZiegelbauer, Karl
- [24] DISCOVERY OF POTENT, ORALLY ACTIVE COMPOUNDS OF TYROSINE KINASE AND SERINE/THREONINE-PROTEIN KINASE INHIBITOR WITH ANTI-TUMOR ACTIVITY IN PRECLINICAL ASSAYSAFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, 2012, 9 (03) : 431 - 439Qiu, Yun-QingZhou, JueKang, Xin-ShanShen-Tu, Jian-ZhongDing, Lie-MingTan, Fen-LaiGuo, JingLi, Lan-Juan
- [25] Discovery and characterization of a new potent orally available CdC7 inhibitor with anti-tumor activityEJC SUPPLEMENTS, 2008, 6 (12): : 116 - 116Montagnoli, A.Vanotti, E.Rainoldi, S.Marchesi, V.Ciavolella, A.Croci, V.Patton, V.Albanese, C.Santocanale, C.Moll, J.
- [26] In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor modelsFRONTIERS IN IMMUNOLOGY, 2024, 15Argueta, ShannonWang, YuxiaoZhao, HongyunDiwanji, NehaGorgievski, MichaelCochran, EdwardGrudzien-Nogalska, EwaD'Alessandro, JosephineMccreedy, BruceProd'homme, ThomasHofmeister, RobertDing, JianGetts, Daniel
- [27] Potent anti-tumor activity correlated with inhibition of DNA damage response genes with highly selective and orally bioavailable CDK12 covalent inhibitorsEUROPEAN JOURNAL OF CANCER, 2018, 103 : E94 - E95Poddutoori, R.Rajagopalan, S.Mukherjee, S.Marappan, S.Samiulla, D.Nayak, S.Sivakumar, S.Ravindra, M.Gore, S.Dhudashiya, A.Charamanna, K.Daginakatte, G.Chelur, S.Ramachandra, M.Samajdar, S.
- [28] The novel aurora kinase inhibitor AS703569 shows potent anti-tumor activity in acute myeloid leukemia (AML).BLOOD, 2007, 110 (11) : 279A - 279ASarno, SamanthaShaw, JamieSpooner, EdwardMa, JianguoClark, AnnDumontet, CharlesRomanelli, Angela
- [29] VEGF-TRAP exhibits potent in vivo anti-tumor activity in acute myeloid leukemia xenograft models.BLOOD, 2006, 108 (11) : 562A - 563ALal, DeepikaPark, Jennifer A.Drake, Allison S.Hoelcle, Brandon J.Wang, Eunice S.
- [30] SY-1365, a potent and selective CDK7 inhibitor, exhibits promising anti-tumor activity in multiple preclinical models of aggressive solid tumorsCANCER RESEARCH, 2017, 77Hu, ShanhuKe, NanRen, YixuanMiljovska, SofijaRajagopal, NishaMcKeown, MichaelOrlando, DavidSprott, KevinChoi, Yoon J.Olson, EricFritz, Christian C.